Kinetics and Thermodynamics of Amyloid Assembly Using a High-Performance Liquid Chromatography-Based Sedimentation Assay

Methods in Enzymology

Volumn 413, Issue , 2006, Pages 34-74

  O'Nuallain, Brian ^a   Thakur, Ashwani K ^a   Williams, Angela D ^a   Bhattacharyya, Anusri M ^a   Chen, Songming ^a   Thiagarajan, Geetha ^a   Wetzel, Ronald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUNTINGTON CHOREA; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVIEW; SEDIMENTATION; STRUCTURE ANALYSIS; THERMODYNAMICS;

AMYLOID; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KINETICS; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; PEPTIDE FRAGMENTS; PEPTIDES; PROPANOLS; PROTEIN STRUCTURE, QUATERNARY; TEMPERATURE; THERMODYNAMICS; TRIFLUOROACETIC ACID;

EID: 33749251222     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)13003-7     Document Type: Review

References (64)

1. Andreu J.M., and Timasheff S.N. The measurement of cooperative protein self-assembly by turbidity and other techniques. Methods Enzymol. 130 (1986) 47-59
2. Berthelier V., Hamilton J.B., Chen S., and Wetzel R. A microtiter plate assay for polyglutamine aggregate extension. Anal. Biochem. 295 (2001) 227-236
3. Bhattacharyya A.M., Thakur A., and Wetzel R. Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction. Proc. Natl. Acad. Sci. USA 102 (2005) 15400-15405
4. Bhattacharyya A.M., Thakur A.K., Hermann V.M., Thiagarajan G., Williams A.D., Chellgren B.W., Creamer T.P., and Wetzel R. Oligoproline effects on polyglutamine conformation and aggregation. J. Mol. Biol. 355 (2006) 524-535
5. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
6. Cannon M.J., Williams A., Wetzel R., and Myszka D.G. Kinetic analysis of Aβ fibril elongation. Anal. Biochem. 328 (2004) 67-75
7. Chen S., Berthelier V., Hamilton J.B., O'Nuallain B., and Wetzel R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41 (2002) 7391-7399
8. Chen S., Berthelier V., Yang W., and Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311 (2001) 173-182
9. Chen S., Ferrone F., and Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA 99 (2002) 11884-11889
10. Chen S., and Wetzel R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci. 10 (2001) 887-891
11. Collins S.R., Douglass A., Vale R.D., and Weissman J.S. Mechanism of prion propagation: Efficient amyloid growth in the absence of oligomeric intermediates. PLoS 2 (2004) 1582-1590
12. Colon W. Analysis of protein structure by solution optical spectroscopy. Methods Enzymol. 309 (1999) 605-632
13. DePace A.H., and Weissman J.S. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nat. Struct. Biol. 9 (2002) 389-396
14. Diamandis E.P. Immunoassays with time-resolved fluorescence spectroscopy: Principles and applications. Clin. Biochem. 21 (1988) 139-150
15. Esler W.P., Stimson E.R., Ghilardi J.R., Felix A.M., Lu Y.A., Vinters H.V., Mantyh P.W., and Maggio J.E. A beta deposition inhibitor screen using synthetic amyloid. Nat. Biotechnol. 15 (1997) 258-263
16. Esler W.P., Stimson E.R., Jennings J.M., Vinters H.V., Ghilardi J.R., Lee J.P., Mantyh P.W., and Maggio J.E. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39 (2000) 6288-6295
17. Evans K.C., Berger E.P., Cho C.-G., Weisgraber K.H., and Lansbury Jr. P.T. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA 92 (1995) 763-767
18. Falk R.H., Comenzo R.L., and Skinner M. The systemic amyloidoses [see comments]. N. Engl. J. Med. 337 (1997) 898-909
19. Ferrone F. Analysis of protein aggregation kinetics. Methods Enzymol. 309 (1999) 256-274
20. Franks F. Storage stabilization of proteins. In: Franks F. (Ed). "Protein Biotechnology: Isolation, Characterization and Stabilization" (1993), Humana Press, New York 489-531
21. Goldsbury C., Frey P., Olivieri V., Aebi U., and Muller S.A. Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J. Mol. Biol. 352 (2005) 282-298
22. Gosal W.S., Morten I.J., Hewitt E.W., Smith D.A., Thomson N.H., and Radford S.E. Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J. Mol. Biol. 351 (2005) 850-864
23. Harper J.D., Lieber C.M., and Lansbury Jr. P.T. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 4 (1997) 951-959
24. Heller J., Kolbert A.C., Larsen R., Ernst M., Bekker T., Baldwin M., Prusiner S.B., Pines A., and Wemmer D.E. Solid-state NMR studies of the prion protein H1 fragment. Protein Sci. 5 (1996) 1655-1661
25. Hilbich C., Kisters-Woike B., Reed J., Masters C.L., and Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease bA4 peptides. J. Mol. Biol. 228 (1992) 460-473
26. Howlett D.R., Jennings K.H., Lee D.C., Clark M.S., Brown F., Wetzel R., Wood S.J., Camilleri P., and Roberts G.W. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4 (1995) 23-32
27. Hurle M.R., Helms L.R., Li L., Chan W., and Wetzel R. A role for destabilizing amino acid replacements in light chain amyloidosis. Proc. Natl. Acad. Sci. USA 91 (1994) 5446-5450
28. Ignatova Z., and Gierasch L.M. Aggregation of a slow-folding mutant of a beta-clam protein proceeds through a monomeric nucleus. Biochemistry 44 (2005) 7266-7274
29. Jarrett J.T., and Lansbury Jr. P.T. Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31 (1992) 12345-12352
30. Jones E.M., and Surewicz W.K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of Mammalian prion amyloids. Cell 121 (2005) 63-72
31. Klunk W.E., Jacob R.F., and Mason R.P. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 309 (1999) 285-305
32. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell. Biol. 10 (2000) 524-530
33. LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309 (1999) 274-284
34. Lomakin A., Benedek G.B., and Teplow D.B. Monitoring protein assembly using quasielastic light scattering spectroscopy. Methods Enzymol. 309 (1999) 429-459
35. Martin J.B. Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 340 (1999) 1970-1980 [published erratum appears in N. Engl. J. Med. [1999] 341, 1407]
36. McCutchen S.L., Colon W., and Kelly J.W. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32 (1993) 12119-12127
37. Meijer A.J., and Codogno P. Regulation and role of autophagy in mammalian cells. Int. J. Biochem. Cell. Biol. 36 (2004) 2445-2462
38. Merkel J.S., Sturtevant J.M., and Regan L. Sidechain interactions in parallel beta sheets: The energetics of cross-strand pairings. Structure Fold Des. 7 (1999) 1333-1343
39. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349 (2003) 583-596
40. Mitraki A., and King J. Protein folding intermediates and inclusion body formation. Biotech. 7 (1989) 690-697
41. Mulkerrin M.G., and Wetzel R. pH dependence of the reversible and irreversible thermal denaturation of γ interferons. Biochem. 28 (1989) 6556-6561
42. Neurath H., Greenstein J.P., Putnam F.W., and Erickson J.O. The chemistry of protein denaturation. Chem. Rev. 34 (1944) 157-265
43. Nichols M.R., Moss M.A., Reed D.K., Cratic-McDaniel S., Hoh J.H., and Rosenberry T.L. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J. Biol. Chem. 280 (2005) 2471-2480
44. Nilsson M.R. Techniques to study amyloid fibril formation in vitro. Methods 34 (2004) 151-160
45. O'Nuallain B., Shivaprasad S., Kheterpal I., and Wetzel R. Thermodynamics of abeta(1-40) amyloid fibril elongation. Biochemistry 44 (2005) 12709-12718
46. O'Nuallain B., Williams A.D., Westermark P., and Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279 (2004) 17490-17499
47. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307 (2005) 262-265
48. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., Arnsdorf M.F., and Lindquist S.L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289 (2000) 1317-1321
49. Sharma D., Shinchuk L.M., Inouye H., Wetzel R., and Kirschner D.A. Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies. Proteins 61 (2005) 398-411
50. Shivaprasad S., and Wetzel R. An intersheet packing interaction in Aβ fibrils mapped by disulfide crosslinking. Biochemistry 43 (2004) 15310-15317
51. Shivaprasad S., and Wetzel R. Scanning cysteine mutagenesis analysis of Aβ(1-40) amyloid fibrils. J. Biol. Chem. 281 (2006) 993-1000
52. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
53. Tanaka M., Chien P., Naber N., Cooke R., and Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428 (2004) 323-328
54. Thakur A., and Wetzel R. Mutational analysis of the structural organization of polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 99 (2002) 17014-17019
55. Wetzel R. Mutations and off-pathway aggregation. Trends Biotechnol. 12 (1994) 193-198
56. Wetzel R. Protein folding and aggregation in the expanded polyglutamine repeat diseases. In: Buchner J., and Kiefhaber T. (Eds). "The Protein Folding Handbook. Part II." (2005), Wiley-VCH, Weinheim 1170-1214
57. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335 (2004) 833-842
58. Williams A.D., Sega M., Chen M., Kheterpal I., Geva M., Berthelier V., Kaleta D.T., Cook K.D., and Wetzel R. Structural properties of Aβ protofibrils stabilized by a small molecule. Proc. Natl. Acad. Sci. USA 102 (2005) 7115-7120
59. Williams A.D., Shivaprasad S., and Wetzel R. Alanine scanning mutagenesis of Aβ(1-40) amyloid fibril stability. J. Mol. Biol. (2006) in press
60. Wood S.J., Maleeff B., Hart T., and Wetzel R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's peptide Ab. J. Mol. Biol. 256 (1996) 870-877
61. Yamaguchi K., Takahashi S., Kawai T., Naiki H., and Goto Y. Seeding-dependent propagation and maturation of amyloid fibril conformation. J. Mol. Biol. 352 (2005) 952-960
62. Yang W., Dunlap J.R., Andrews R.B., and Wetzel R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11 (2002) 2905-2917
63. Zagorski M.G., Yang J., Shao H., Ma K., Zeng H., and Hong A. Methodological and chemical factors affecting amyloid-β amyloidogenicity. Methods Enzymol. 309 (1999) 189-204
64. Zhang S., Iwata K., Lachenmann M.J., Peng J.W., Li S., Stimson E.R., Lu Y., Felix A.M., Maggio J.E., and Lee J.P. The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J. Struct. Biol. 130 (2000) 130-141